F13.21
Sedative, hypnotic or anxiolytic dependence, in remission
Clinical Classification Guidelines
Inclusion Terms
- Sedative, hypnotic or anxiolytic use disorder, moderate, in early remission
- Sedative, hypnotic or anxiolytic use disorder, moderate, in sustained remission
- Sedative, hypnotic or anxiolytic use disorder, severe, in early remission
- Sedative, hypnotic or anxiolytic use disorder, severe, in sustained remission
Medical Intelligence & Overview
ICD-10 code F13.21 refers to a condition where an individual previously experienced dependence on sedative, hypnotic, or anxiolytic medications but has now entered a period of remission. These medications are often used to treat issues like anxiety, insomnia, or agitation, but repeated or prolonged use can lead to dependence. In remission, the person no longer meets the clinical criteria for dependence, although they must continue to monitor their health to prevent relapse.
Causes & Symptoms
Clinical Causes: Prolonged or misuse of sedative, hypnotic, or anxiolytic medications Self-medicating for underlying anxiety, sleep disorders, or stress Lack of proper medical guidance during medication use Genetic predisposition to substance dependence Psychological factors, such as trauma or mental health conditions
Key Symptoms: History of dependence on sedative, hypnotic, or anxiolytic drugs Cravings or strong desires to use these medications, which may now be absent Previous difficulties in stopping medication use Potential lingering psychological dependence or risk of relapse Residual effects related to past medication use, such as sleep disturbances or anxiety
Diagnostic & Treatment
Diagnosis Path: Diagnosis of dependence in remission involves a comprehensive assessment by a healthcare professional. The clinician reviews the patient's history of medication use, evaluates for signs of ongoing dependence or relapse, and considers the duration and severity of previous dependence—whether it was moderate or severe. The criteria include evidence of past dependence and current absence of symptoms, with attention to the period since remission began.
Treatment Protocols: While the ICD-10 code F13.21 indicates remission, ongoing management might include:
Clinical Advice & FAQs
Billing Guidance
Is F13.21 a billable ICD-10 code?
Yes, F13.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.21?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference